SAREPTA THERAPEUTICS, INC. Letters of Credit Outstanding, Amount
SAREPTA THERAPEUTICS, INC. (SRPT) had Letters of Credit Outstanding, Amount of $10.70 million as of 2015-09-30, per its 10-K filed 2018-03-01.
Discontinued › Notes › Other Liabilities
us-gaap:LettersOfCreditOutstandingAmount · last filed 2018-03-01
- 2015-09-30: Letters of Credit Outstanding, Amount $10.70M.
- 2013-02-28: Letters of Credit Outstanding, Amount $7.30M.
| Period end | Letters of Credit Outstanding, Amount |
|---|---|
| 2015-09-30 | $10.70M 10-K · filed 2018-03-01 |
| 2013-02-28 | $7.30M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |